A Phase I, Randomized, Double-blind, Placebo-controlled, Rising-dose Study to Assess the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of Single IV Doses of AR09 in Healthy Subjects

Trial Profile

A Phase I, Randomized, Double-blind, Placebo-controlled, Rising-dose Study to Assess the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of Single IV Doses of AR09 in Healthy Subjects

Discontinued
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2016

At a glance

  • Drugs AR 09 (Primary)
  • Indications Anaesthesia
  • Focus Adverse reactions
  • Sponsors Arbor Pharmaceuticals
  • Most Recent Events

    • 22 Apr 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 30 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top